GWRE — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-06-05

• Income (loss) before provision for (benefit from) income taxes118,814 11 8,410 2

• We expect our research and development expenses to increase in absolute dollars due to inflation and investments to enhance and develop our products and services, but decrease as a percentage of revenue as we focus on hiring in lower cost regions. We continue to dedicate internal resources to develo…

• We expect our sales and marketing expenses to increase in absolute dollars as we support new product initiatives and ongoing subscription and cloud growth, but to grow more slowly than revenue over time. As a result, we expect sales and marketing expense as a percentage of revenue to decline as we r…

• Interest expense for the nine months ended April 30, 2026 consists of stated interest of $6.5 million, non-cash interest expense of $2.9 million related to amortization of debt issuance costs, and $0.5 million of commitment fees on our undrawn 2025 Credit Facility. Interest expense for the nine mont…

• Other income (expense), net during the three months ended April 30, 2026 was expense of $18.9 million, compared to income of $34.1 million during the same period a year ago. This change was primarily driven by a foreign currency loss of $20.1 million during the three months ended April 30, 2026, com…

Text removed vs the prior filing · source: 10-Q · 2026-03-06

• customer demands. In certain cases, we may also acquire skills and technologies to manage our cloud infrastructure and accelerate our time to market for new products, solutions, and upgrades.

• change in fair value of strategic investments. Additionally, inflation levels and political uncertainty are impacting the global economy and have magnified the impact of these disruptions.

• Term license revenue increased by $0.4 million during the six months ended January 31, 2026, compared to the same period a year ago, primarily due to an annual renewal after the end of a multi-year commitment entered into during the three months ended October 31, 2020 by a customer, partially offset…

• Our research and development headcount was 1,340 at January 31, 2026, compared with 1,144 at January 31, 2025.

• We expect our research and development expenses to increase in absolute dollars due to inflation and investments to enhance and develop our product and services, but decrease as a percentage of revenue as we focus on hiring in lower cost regions. We continue to dedicate internal resources to develop…

Text added vs the prior filing · source: 10-Q · 2026-06-05

• We use AI technologies in our offerings and business, and we are continuing to make investments in expanding our AI capabilities in our products, professional services, and tools, including by enhancing existing or developing new product features and functionality that use or incorporate AI technolo…

• protection of our own proprietary code that is commingled with such code. Finally, to the extent we use third-party AI technologies to develop software code, the terms of use of these tools may state that the third-party provider retains rights in the generated code.

• The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Exchange Act. Further, our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the United States District Court for the Northern Di…

• change itself could also lead to a default under agreements governing our existing or future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and settle the 2029 …

Text removed vs the prior filing · source: 10-Q · 2026-03-06

• We use AI technologies in our offerings and business, and we are continuing to make investments in expanding our AI capabilities in our products, professional services, and tools, including by enhancing existing or developing new product features and functionality that use or incorporate AI technolo…

• investment will be required to continuously improve our use of AI technologies. As with many technological innovations, there are significant risks involved in developing, maintaining and deploying these technologies and there can be no assurance that the usage of or our investments in such technolo…

• experience delays between the time we incur expenses associated with research and development and the time we generate revenue, if any, from such expenses.

• against us could result in substantial costs and divert our management’s attention from our business, which could seriously harm our business, results of operations, and financial condition.

• The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Exchange Act. Further, our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the

Text added vs the prior filing · source: 10-Q · 2026-06-05

• Winston King, Chief Administrative Officer, General Counsel, and Secretary

• (1) Mr. Cooper terminated his Rule 10b5-1 trading arrangement, which was originally adopted on October 14, 2025. The aggregate number of shares reported in this table represents the total shares originally authorized for potential sale under the arrangement prior to its termination.

• (2) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) with sales occurring periodically from the estimated selling start date of June 22, 2026 and continuing through the earlier of the execution of all trading orders pursuant to the plan and December 31, 2026.

• (3) This number represents an estimate of the maximum number of shares of common stock that may be sold pursuant to the trading plan, based on an assumed 40% tax withholding rate and the maximum payout of PSUs that have not yet achieved or vested. The actual number of shares sold will depend on the …

• (4) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) with sales occurring periodically from the estimated selling start date of July 9, 2026 and continuing through the earlier of the execution of all trading orders pursuant to the plan and December 31, 2026. The amendment cha…

Text removed vs the prior filing · source: 10-Q · 2026-03-06

• (1) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) with sales under this amendment occurring periodically from the estimated selling start date of April 14, 2026 and continuing through the earlier of the execution of all trading orders pursuant to the plan and December 31, …